Argon inhalation attenuates retinal apoptosis after ischemia/reperfusion injury in a time- And dose-dependent manner in rats

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Ulbrich, Felix ^a   Schallner, Nils ^a   Coburn, Mark ^b   Loop, Torsten ^a   Lagrèze, Wolf Alexer ^a   Biermann, Julia ^a   Goebel, Ulrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; ISCHEMIC POSTCONDITIONING; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MUELLER CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA ISCHEMIA; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; RETINA; SPRAGUE DAWLEY RAT;

RATTUS;

ADMINISTRATION, INHALATION; ANIMALS; APOPTOSIS; ARGON; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RETINA; RNA, MESSENGER;

EID: 84919632667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115984     Document Type: Article

References (50)

1. Verma D (1993) Pathogenesis of diabetic retinopathy-the missing link? Med Hypotheses 41: 205-210.
2. Archer DB (1976) Tributary vein obstruction: pathogenesis and treatment of sequelae. Doc Ophthalmol 40: 339-360.
3. Hayreh SS (1978) Ischemic optic neuropathy. Int Ophthalmol 1: 9-18.
4. Nickells RW (1996) Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma 5: 345-356.
5. Schmidt KG, Pillunat LE, Osborne NN (2004) [Ischemia and hypoxia. An attempt to explain the different rates of retinal ganglion cell death in glaucoma]. Ophthalmologe 101: 1071-1075.
6. Zhang C, Rosenbaum DM, Shaikh AR, Li Q, Rosenbaum PS, et al. (2002) Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci 43: 3059-3066.
7. Joo CK, Choi JS, Ko HW, Park KY, Sohn S, et al. (1999) Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci 40: 713-720.
8. Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78: 723-736.
9. Mukaida Y, Machida S, Masuda T, Tazawa Y (2004) Correlation of retinal function with retinal histopathology following ischemia-reperfusion in rat eyes. Curr Eye Res 28: 381-389.
10. Schallner N, Fuchs M, Schwer CI, Loop T, Buerkle H, et al. (2012) Postconditioning with inhaled carbon monoxide counteracts apoptosis and neuroinflammation in the ischemic rat retina. PLoS One 7: e46479.
11. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, et al. (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59: 467-477.
12. Soldatov PE, D'Iachenko A I, Pavlov BN, Fedotov AP, Chuguev AP (1998) [Survival of laboratory animals in argon-containing hypoxic gaseous environments]. Aviakosm Ekolog Med 32: 33-37.
13. Irani Y, Pype JL, Martin AR, Chong CF, Daniel L, et al. (2011) Noble gas (argon and xenon)-saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation. Nephron Extra 1: 272-282.
14. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, et al. (2007) Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105: 562-569.
15. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W (2006) Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105: 187-197.
16. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, et al. (2010) Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 235: 886-891.
17. Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ (2003) Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 96: 746-749, table of contents.
18. Coburn M, Rossaint R (2012) Argon in the fast lane: noble gases and their neuroprotective effects. Crit Care Med 40: 1965-1966.
19. Dickinson R, Franks NP (2010) Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care 14: 229.
20. Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, et al. (2011) Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 39: 1448-1453.
21. Koblin DD, Fang Z, Eger EI, 2nd, Laster MJ, Gong D, et al. (1998) Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 87: 419-424.
22. Kamphuis W, Dijk F, van Soest S, Bergen AA (2007) Global gene expression profiling of ischemic preconditioning in the rat retina. Mol Vis 13: 1020-1030.
23. Li SY, Fu ZJ, Ma H, Jang WC, So KF, et al. (2009) Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci 50: 836-843.
24. Wang L, Li C, Guo H, Kern TS, Huang K, et al. (2011) Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One 6: e23194.
25. Biermann J, Lagreze WA, Dimitriu C, Stoykow C, Goebel U (2010) Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury. Invest Ophthalmol Vis Sci 51: 3784-3791.
26. Biermann J, Lagreze WA, Schallner N, Schwer CI, Goebel U (2011) Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. Mol Vis 17: 1275-1286.
27. Zhao H, Sapolsky RM, Steinberg GK (2006) Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 26: 1114-1121.
28. Lee JJ, Li L, Jung HH, Zuo Z (2008) Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 108: 1055-1062.
29. Jehle T, Dimitriu C, Auer S, Knoth R, Vidal-Sanz M, et al. (2008) The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 246: 1255-1263.
30. Fischer D, Pavlidis M, Thanos S (2000) Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture. Invest Ophthalmol Vis Sci 41: 3943-3954.
31. Biermann J, Grieshaber P, Goebel U, Martin G, Thanos S, et al. (2010) Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci 51: 526-534.
32. Schallner N, Schwemmers S, Schwer CI, Froehlich C, Stoll P, et al. (2011) p38beta-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro. Eur J Pharmacol 670: 58-66.
33. Burda J, Danielisova V, Nemethova M, Gottlieb M, Matiasova M, et al. (2006) Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol 26: 1141-1151.
34. Schallner N, Romao CC, Biermann J, Lagreze WA, Otterbein LE, et al. (2013) Carbon monoxide abrogates ischemic insult to neuronal cells via the soluble guanylate cyclase-cGMP pathway. PLoS One 8: e60672.
35. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, et al. (2009) Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 13: R206.
36. Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi MP, et al. (2012) The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 40: 1724-1730.
37. Peng T, Britton GL, Kim H, Cattano D, Aronowski J, et al. (2013) Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. CNS Neurosci Ther 19: 773-784.
38. David HN, Haelewyn B, Degoulet M, Colomb DG, Jr., Risso JJ, et al. (2012) Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 7: e30934.
39. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, et al. (2009) Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 460: 232-236.
40. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776.
41. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
42. Antonsson B, Martinou JC (2000) The Bcl-2 protein family. Exp Cell Res 256: 50-57.
43. Yi JH, Park SW, Kapadia R, Vemuganti R (2007) Role of transcription factors in mediating postischemic cerebral inflammation and brain damage. Neurochem Int 50: 1014-1027.
44. Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, et al. (2002) Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 22: 8466-8475.
45. Chiarugi A (2002) Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons. Brain Res Mol Brain Res 109: 179-188.
46. Kaltschmidt C, Kaltschmidt B, Baeuerle PA (1993) Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev 43: 135-147.
47. Meberg PJ, Kinney WR, Valcourt EG, Routtenberg A (1996) Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity. Brain Res Mol Brain Res 38: 179-190.
48. Agnihotri S, Czap A, Staff I, Fortunato G, McCullough LD (2011) Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. J Neuroinflammation 8: 160.
49. Aronowski J, Zhao X (2011) Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke 42: 1781-1786.
50. David HN, Haelewyn B, Risso JJ, Abraini JH (2013) Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol 386: 91-95.